Autoinjectors Market Growth

Autoinjectors Market Growth at a CAGR of 5.7% during the forecast period 2026-2035

 

According to a recently published report by Roots Analysis, the increasing prevalence of chronic diseases, and rising demand for self-administration devices (specifically in home care settings) are driving the autoinjectors market

Autoinjectors Market Overview

The global autoinjectors market is anticipated to reach USD 299 billion by 2035, growing at a CAGR of 5.7% during the forecast period 2026-2035. 

Autoinjectors are self-administration devices designed to deliver a dose of a particular medication into the body. These drug delivery devices have gained significant traction in the healthcare domain, owing to the various advantages offered by them, including rapid and efficient drug delivery, precise dosing and improved medication adherence. With the rising prevalence of chronic diseases (such as diabetes, multiple sclerosis and rheumatoid arthritis), autoinjectors have proven to be ideal for patients requiring frequent injections. In addition, they can be tailored to meet specific pharmaceutical and patient requirements. Notably, advancements in autoinjector technology have led to improvements in features, such as needle safety, adjustable needle depth and connectivity options.

Browse 215+ figures and 335+ market data tables spread across 890+ pages and detailed Table of Content on “Global Autoinjectors Market Industry Trends and Global Forecasts, till 2035 by Distribution by Usability (Disposable Autoinjector and Reusable Auto injector), Route of Administration (Subcutaneous, Intramuscular and Intravenous), Type of Molecule Delivered (Proteins, Antibodies, Small Molecules, Peptides and Others), Type of Actuation Mechanism (Manual and Automatic), Volume of Container (Less than 1mL, 1-2 mL and More than 2 mL), End-user (Home Care Settings, Hospitals and Clinics, and Ambulatory Surgical Centers), Target Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Weight Loss, Anaphylaxis, Migraine and Others) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America)” here: https://www.rootsanalysis.com/reports/autoinjectors-market/293.html

Market Drivers

Several factors are propelling the growth of the autoinjectors market. The trend towards self-administration devices, driven by patient preference and convenience, drives the autoinjectors market. Further, autoinjectors reduce healthcare costs by moving treatment from hospitals to home settings, thereby resulting in cost saving for both patients and healthcare providers. Notably, continuous innovation in the autoinjectors market in terms of design, functionality and usability, has led to their widespread adoption.

Market Restraints 

While the autoinjectors market is experiencing substantial growth, there are certain restraints that can hinder the growth of this industry. One of the primary restraints in this domain is the complexity associated with the development of an autoinjector combination product to deliver highly viscous drugs. Further, certain patients might encounter difficulties in properly operating the device, potentially resulting in adverse effects. Stringent regulatory processes may increase the development costs and delay the market entry for new products.

Growth Factors

Despite the aforementioned challenges, various growth factors continue to drive the autoinjectors market forward. One of the primary factors include the entry of a large number of drugs into the market (as a number of drugs are likely to lose their market exclusivity), which can be administered via autoinjectors. In addition, the increased investments in R&D by manufacturers are fostering innovation in autoinjectors market leading to the development of more user-friendly autoinjectors.

Autoinjectors Market Segments 

Based on usability, the market is segmented into disposable autoinjector and reusable auto injector

• The disposable autoinjector segment dominates the autoinjectors market by capturing close to 90% of the overall revenue share. 
• The reusable auto injector segment is anticipated to be the fastest growing segment in this industry, with annualized rate  (CAGR) of over 7% during the forecast period.

Based on the route of administration, the market is segmented into intramuscular and subcutaneous route

• The autoinjectors designed for subcutaneous drug delivery captures the largest revenue share of close to 90% in the autoinjectors market.
• The autoinjectors designed for subcutaneous drug delivery is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of 6.5% during the forecast period.

Based on the type of molecule delivered, the market is segmented into antibodies, proteins, peptides, small molecules and others

• The autoinjectors delivering proteins capture the largest revenue share of close to 50% in the autoinjectors market.
• The autoinjectors delivering peptides is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of over 14% during the forecast period.

Based on the type of actuation mechanism, the market is segmented into manual actuation and automatic actuation

• The autoinjectors with automatic actuation mechanism capture the largest revenue share of around 80% in the autoinjectors market.
• The autoinjectors with automatic actuation mechanism is anticipated to show the highest annualized growth rate of 6.5% during the forecast period.

Based on the volume of container, the market is segmented into less than 1 mL, 1-2 mL and more than 2 mL

• The autoinjectors capable of storing 1-2 mL of drug captures the largest revenue share of close to 40% in the autoinjectors market.
• The autoinjectors capable of storing more than 2 mL is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of 8% during the forecast period.

Based on end user, the market is segmented into ambulatory surgical centers, home care settings, and hospitals and clinics

• The autoinjectors for home care settings currently dominate the autoinjectors market, by capturing 80% of the overall revenue share. 
• The autoinjector for home care settings is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of over 6.5% during the forecast period.

Based on the target indication, the market is segmented into anaphylaxis, diabetes, weight loss, migraine, multiple sclerosis, rheumatoid arthritis, and others

• The autoinjectors intended for the treatment of rheumatoid arthritis are anticipated to dominate the current autoinjectors market, by capturing 25% share.
• Autoinjectors intended for treatment of weight loss is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of more than 16% during the forecast period.

Based on the Regional Insights, the market is segmented North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America

• North America is likely to dominate the autoinjectors market, by capturing the largest revenue share of close to 55%.
• In Asia Pacific, the autoinjectors market is likely to demonstrate considerable growth (CAGR of around 8%) during the forecast period.

Key Companies Profiled 

The autoinjectors market report also includes profiles of key players (listed below) that offer autoinjector and autoinjector combination products:

• Amgen
• Antares Pharma
• ChemProtect SK
• Elcam Medical
• Eli Lilly and Company
• Jiangsu Delfu Medical Device
• Kindeva Drug Delivery
• Merck
• Novartis
• Novo Nordisk
• Oval Medical Technologies
• Owen Mumford
• PreciHealth
• Recipharm
• Sanofi
• SHL Medical
• Teva Pharmaceuticals
• Union Medico 
• Ypsomed

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/autoinjectors-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com